Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
QuintilesIMS
Mallinckrodt
Harvard Business School
Cipla
UBS
Chinese Patent Office
US Army

Generated: April 26, 2018

DrugPatentWatch Database Preview

PREVALITE Drug Profile

« Back to Dashboard

When do Prevalite patents expire, and when can generic versions of Prevalite launch?

Prevalite is a drug marketed by Upsher-smith Labs and is included in one NDA.

The generic ingredient in PREVALITE is cholestyramine. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for PREVALITE
Drug patent expirations by year for PREVALITE
Pharmacology for PREVALITE

US Patents and Regulatory Information for PREVALITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-001 Feb 22, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-002 Oct 30, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Express Scripts
Moodys
Baxter
US Department of Justice
McKesson
Citi
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.